BRIEF published on 07/15/2025 at 14:05, 6 months 21 days ago Eckert & Ziegler's Training Program Recognized for Excellence Training Excellence Berlin Chamber Award Trainee Retention Career Prospects Future Applications
PRESS RELEASE published on 07/15/2025 at 14:00, 6 months 21 days ago Eckert & Ziegler: Outstanding Training Quality Once Again Awarded Eckert & Ziegler SE awarded for exceptional training quality by Berlin Chamber of Industry and Commerce for the fourth consecutive time, emphasizing practical experience and career prospects for trainees Eckert & Ziegler Career Prospects Training Quality Berlin Chamber Of Industry And Commerce Trainee Team
BRIEF published on 06/18/2025 at 16:10, 7 months 17 days ago Eckert & Ziegler SE déclare un dividende de 0,50 € lors de son assemblée générale annuelle Actionnaires Dividende Assemblée Générale Annuelle Eckert & Ziegler SE Exercice Financier 2024
BRIEF published on 06/18/2025 at 16:10, 7 months 17 days ago Eckert & Ziegler SE Declares EUR 0.50 Dividend at Annual General Meeting Annual General Meeting Shareholders Dividend Financial Year 2024 Eckert & Ziegler SE
PRESS RELEASE published on 06/18/2025 at 16:05, 7 months 17 days ago Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE's Annual General Meeting approves dividend of EUR 0.50 per share for 2024 fiscal year. Detailed voting results available online Annual General Meeting Shareholders Voting Results Dividend Eckert & Ziegler SE
BRIEF published on 06/05/2025 at 10:05, 8 months ago Eckert & Ziegler se développe avec l'approbation d'Illuccix® en Allemagne Gallium-68 Médecine Nucléaire Cancer De La Prostate Illuccix® Imagerie PSMA-PET
BRIEF published on 06/05/2025 at 10:05, 8 months ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 8 months ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 8 months 6 days ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
BRIEF published on 05/30/2025 at 10:05, 8 months 6 days ago Eckert & Ziegler organise avec succès le Boston Radionuclide Theranostics Forum Oncologie De Précision Produits Radiopharmaceutiques Collaboration Industrielle Forum Théranostique Informations Sur Les Événements
Published on 02/05/2026 at 17:35, 29 minutes ago Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 1 hour 24 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 2 hours 19 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 2 hours 54 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 3 hours 14 minutes ago High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 17:55, 9 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 24 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 24 minutes ago UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI
Published on 02/05/2026 at 17:05, 59 minutes ago European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
Published on 02/05/2026 at 18:00, 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
Published on 02/05/2026 at 18:00, 4 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 janvier 2026
Published on 02/05/2026 at 17:48, 15 minutes ago NRJ GROUP - Avis financier - Chiffre d'affaires 2025
Published on 02/05/2026 at 17:35, 29 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
